Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Net Income (2016 - 2024)

Historic Net Income for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2024 value amounting to $3000.0.

  • Lifecore Biomedical, Inc. \De\'s Net Income rose 10013.12% to $3000.0 in Q2 2024 from the same period last year, while for Feb 2025 it was $3000.0, marking a year-over-year decrease of 9923.66%. This contributed to the annual value of $2.7 million for FY2024, which is 10759.19% up from last year.
  • As of Q2 2024, Lifecore Biomedical, Inc. \De\'s Net Income stood at $3000.0, which was up 10013.12% from $847000.0 recorded in Q1 2024.
  • Lifecore Biomedical, Inc. \De\'s 5-year Net Income high stood at $1.9 million for Q3 2023, and its period low was -$51.6 million during Q2 2022.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Net Income averaged around -$10.2 million, with its median value being -$3.6 million (2022).
  • Its Net Income has fluctuated over the past 5 years, first tumbled by 241057.11% in 2020, then skyrocketed by 14357.83% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Net Income (Quarter) stood at -$4.0 million in 2020, then crashed by 1039.91% to -$46.0 million in 2021, then soared by 92.17% to -$3.6 million in 2022, then surged by 99.33% to -$24000.0 in 2023, then soared by 112.5% to $3000.0 in 2024.
  • Its Net Income was $3000.0 in Q2 2024, compared to $847000.0 in Q1 2024 and -$24000.0 in Q4 2023.